Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, Alqurashi W, Arkwright P, Baldwin JL, Ben-Shoshan M, Bernstein J, Bingemann T, Blumchen K, Byrne A, Bognanni A, Campbell D, Campbell R, Chagla Z, Chan ES, Chan J, Comberiati P, Dribin TE, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Grayson MH, Horner CC, Hourihane J, Katelaris CH, Kim H, Kelso JM, Lang D, Ledford D, Levin M, Lieberman J, Loh R, Mack D, Mazer B, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Oppenheimer J, Perrett KP, Ramsey A, Rank M, Robertson K, Sheikh J, Spergel JM, Stukus D, Tang MLK, Tracy JM, Turner PJ, Whalen-Browne A, Wallace D, Wang J, Waserman S, Witry JK, Worm M, Vander Leek TK, Golden DBK. Greenhawt M, et al. Among authors: byrne a. J Allergy Clin Immunol Pract. 2021 Oct;9(10):3546-3567. doi: 10.1016/j.jaip.2021.06.006. Epub 2021 Jun 18. J Allergy Clin Immunol Pract. 2021. PMID: 34153517 Free PMC article. Review.
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
Fleischer DM, Greenhawt M, Sussman G, Bégin P, Nowak-Wegrzyn A, Petroni D, Beyer K, Brown-Whitehorn T, Hebert J, Hourihane JO, Campbell DE, Leonard S, Chinthrajah RS, Pongracic JA, Jones SM, Lange L, Chong H, Green TD, Wood R, Cheema A, Prescott SL, Smith P, Yang W, Chan ES, Byrne A, Assa'ad A, Bird JA, Kim EH, Schneider L, Davis CM, Lanser BJ, Lambert R, Shreffler W. Fleischer DM, et al. Among authors: byrne a. JAMA. 2019 Mar 12;321(10):946-955. doi: 10.1001/jama.2019.1113. JAMA. 2019. PMID: 30794314 Free PMC article. Clinical Trial.
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
Fleischer DM, Shreffler WG, Campbell DE, Green TD, Anvari S, Assa'ad A, Bégin P, Beyer K, Bird JA, Brown-Whitehorn T, Byrne A, Chan ES, Cheema A, Chinthrajah S, Chong HJ, Davis CM, Ford LS, Gagnon R, Greenhawt M, Hourihane JO, Jones SM, Kim EH, Lange L, Lanser BJ, Leonard S, Mahler V, Maronna A, Nowak-Wegrzyn A, Oriel RC, O'Sullivan M, Petroni D, Pongracic JA, Prescott SL, Schneider LC, Smith P, Staab D, Sussman G, Wood R, Yang WH, Lambert R, Peillon A, Bois T, Sampson HA. Fleischer DM, et al. Among authors: byrne a. J Allergy Clin Immunol. 2020 Oct;146(4):863-874. doi: 10.1016/j.jaci.2020.06.028. Epub 2020 Jul 10. J Allergy Clin Immunol. 2020. PMID: 32659313 Free article. Clinical Trial.
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
O'B Hourihane J, Beyer K, Abbas A, Fernández-Rivas M, Turner PJ, Blumchen K, Nilsson C, Ibáñez MD, Deschildre A, Muraro A, Sharma V, Erlewyn-Lajeunesse M, Zubeldia JM, De Blay F, Sauvage CD, Byrne A, Chapman J, Boralevi F, DunnGalvin A, O'Neill C, Norval D, Vereda A, Skeel B, Adelman DC, du Toit G. O'B Hourihane J, et al. Among authors: byrne a. Lancet Child Adolesc Health. 2020 Oct;4(10):728-739. doi: 10.1016/S2352-4642(20)30234-0. Epub 2020 Jul 20. Lancet Child Adolesc Health. 2020. PMID: 32702315 Clinical Trial.
Mass food challenges in a vacant COVID-19 stepdown facility: Exceptional opportunity provides a model for the future.
Byrne AM, Trujillo J, Fitzsimons J, Mohammed T, Ghent R, O'Carroll C, Coghlan D, Hourihane JO, Alsalemi A, Cassidy A, Corbet E, Creighton R, d'Art Y, Farren L, Flanagan R, Flynn N, Franklin R, Gray C, Harding P, Hendrick C, Heraghty F, Hurley S, Kavanagh V, Lad D, Leddy K, Lewis S, McGlynn T, O'Connor D, O'Neill P, O'Shea O, O'Toole A, Quinn R, Reid A, Russell A, Ruth E, Rynne A, Sanneerappa PB, Sheehan M, Thompson C, Tobin C, Trayer J, Wallace A, Walsh N, Wilson F; Children's Health Ireland (CHI) Food Challenge Initiative Team. Byrne AM, et al. Pediatr Allergy Immunol. 2021 Nov;32(8):1756-1763. doi: 10.1111/pai.13580. Epub 2021 Jul 28. Pediatr Allergy Immunol. 2021. PMID: 34152649 Free PMC article.
Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines.
Hourihane JO, Byrne AM, Blümchen K, Turner PJ, Greenhawt M. Hourihane JO, et al. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2562-2566. doi: 10.1016/j.jaip.2021.04.025. Epub 2021 May 4. J Allergy Clin Immunol Pract. 2021. PMID: 34246432 Free PMC article. No abstract available.
1,203 results